BioSpace News Archive

The Mom and Her Autistic Daughter, is a true story, and you may want to watch the book trailer on YouTube.

MTF Biologics announced a new tissue recovery relationship with Southwest Transplant Alliance (STA) headquartered in Dallas, Tx. STA will begin recovering musculoskeletal and dermal tissues on behalf of MTF Biologics in February.

Monash University biospectroscopists have been issued a US patent for the diagnostic technology they hope will one day help doctors to diagnose and treat patients much faster than current pathology methods.

The Virginia Institute of Robotic Surgery at Reston Hospital Center has acquired Synaptive Medical’s product suite, an integrated set of neurosurgery tools designed to unite surgical planning, imaging and navigation for more efficient brain surgery and potentially improved patient outcomes.

Please be advised that Dan Vandal, Parliamentary Secretary to the Minister of Indigenous Services, will announce two community infrastructure projects in Lac-Simon.

INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced today an update to its intention to proceed with a consolidation of its issued and outstanding shares with a newly proposed reduced share consolidation ratio of one new share for every five old shares (1:5) in connection with its proposed listing on Nasdaq Stock Market LLC (“Nasdaq”).

“While caring for my mom I needed help,” said an inventor from Dobbs Ferry, N.Y. “This inspired me to develop this wearable accessory through which she could hold on to exercise.”

Valens GroWorks Corp.is pleased to announce that it has entered into a multi-year extraction services agreement (the “Agreement”) with privately-held Sundial Growers Inc. (“Sundial”) for cannabis extraction services.

TaiwanJ Pharmaceuticals recently announced the results of phase II clinical trial of JKB-122 for the treatment of refractory Autoimmune Hepatitis (AIH) patients that demonstrated improvement on targeted objectives and relevant biomarkers from the JKB-122 treated subjects after the completion of 24-week study.

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on March 29, 2019 to holders of record on March 8, 2019.